HIV reservoirs are dominated by genetically younger and clonally enriched proviruses.

HIV reservoir genomic integrity low-level viremia molecular dating persistence phylogenetics proviral landscape rebound

Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
16 Nov 2023
Historique:
medline: 17 11 2023
pubmed: 17 11 2023
entrez: 16 11 2023
Statut: aheadofprint

Résumé

Characterizing the human immunodeficiency virus (HIV) reservoir that endures despite antiretroviral therapy (ART) is critical to cure efforts. We observed that the oldest proviruses persisting during ART were exclusively defective, while intact proviruses (and rebound HIV) dated to nearer ART initiation. This helps explain why studies that sampled sub-genomic proviruses on-ART (which are largely defective) routinely found sequences dating to early infection, whereas those that sampled replication-competent HIV found almost none. Together with our findings that intact proviruses were more likely to be clonal, and that on-ART low-level/isolated viremia originated from proviruses of varying ages (including possibly defective ones), our observations indicate that (i) on-ART and rebound viremia can have distinct within-host origins, (ii) intact proviruses have shorter lifespans than grossly defective ones and thus depend more heavily on clonal expansion for persistence, and (iii) an HIV reservoir predominantly "dating" to near ART initiation will be substantially adapted to within-host pressures, complicating immune-based cure strategies.

Identifiants

pubmed: 37971267
doi: 10.1128/mbio.02417-23
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0241723

Commentaires et corrections

Type : UpdateOf

Auteurs

Natalie N Kinloch (NN)

Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.

Aniqa Shahid (A)

Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.

Winnie Dong (W)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.

Don Kirkby (D)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.

Bradley R Jones (BR)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Bioinformatics Program, University of British Columbia, Vancouver, British Columbia, Canada.

Charlotte J Beelen (CJ)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.

Daniel MacMillan (D)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.

Guinevere Q Lee (GQ)

Infectious Diseases Division, Department of Medicine, Weill Cornell Medical College, New York, New York, USA.

Talia M Mota (TM)

Infectious Diseases Division, Department of Medicine, Weill Cornell Medical College, New York, New York, USA.

Hanwei Sudderuddin (H)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Experimental Medicine Program, University of British Columbia, Vancouver, British Columbia, Canada.

Evan Barad (E)

Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.

Marianne Harris (M)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Department of Family Practice, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Chanson J Brumme (CJ)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

R Brad Jones (RB)

Infectious Diseases Division, Department of Medicine, Weill Cornell Medical College, New York, New York, USA.

Mark A Brockman (MA)

Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
Department of Molecular Biology and Biochemistry, Faculty of Science, Simon Fraser University, Burnaby, British Columbia, Canada.

Jeffrey B Joy (JB)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Bioinformatics Program, University of British Columbia, Vancouver, British Columbia, Canada.
Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Zabrina L Brumme (ZL)

Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.

Classifications MeSH